These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 10604222

  • 1. Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group.
    Ludwig D, Stange EF.
    Z Gastroenterol; 1999 Nov; 37(11):1085-91. PubMed ID: 10604222
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
    Reinisch W, Panés J, Lémann M, Schreiber S, Feagan B, Schmidt S, Sturniolo GC, Mikhailova T, Alexeeva O, Sanna L, Haas T, Korom S, Mayer H.
    Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 4. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 5. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb 01; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 7. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
    Hinterleitner TA, Petritsch W, Aichbichler B, Fickert P, Ranner G, Krejs GJ.
    Z Gastroenterol; 1997 Aug 15; 35(8):603-8. PubMed ID: 9297775
    [Abstract] [Full Text] [Related]

  • 8. Predictive factors of azathioprine prescription in adult patients with Crohn's disease.
    Karoui S, Bibani N, Serghini M, Kallel L, Ben Mustapha N, Boubaker J, Filali A.
    Hepatogastroenterology; 2010 Aug 15; 57(98):283-7. PubMed ID: 20583428
    [Abstract] [Full Text] [Related]

  • 9. Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.
    Pinto AL, Chebli LA, Ribeiro MS, Pace FH, Moraes JP, do Amaral FJ, Gaburri PD, Meirelles de Souza AF, Chebli JM.
    Med Sci Monit; 2009 May 15; 15(5):PI19-26. PubMed ID: 19396048
    [Abstract] [Full Text] [Related]

  • 10. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.
    Dig Liver Dis; 2004 May 15; 36(5):342-7. PubMed ID: 15191204
    [Abstract] [Full Text] [Related]

  • 11. A pilot study comparing hydrocortisone premedication to concomitant azathioprine treatment in preventing loss of response to infliximab.
    Mantzaris GJ, Viazis N, Petraki K, Papamichael K, Theodoropoulos I, Roussos A, Karakoidas C, Koilakou S, Raptis N, Smyrnidis A, Agalos G, Karamanolis DG.
    Eur J Gastroenterol Hepatol; 2009 Sep 15; 21(9):1042-8. PubMed ID: 20139856
    [Abstract] [Full Text] [Related]

  • 12. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
    Panés J, López-Sanromán A, Bermejo F, García-Sánchez V, Esteve M, Torres Y, Domènech E, Piqueras M, Gomez-García M, Gutiérrez A, Taxonera C, Sans M, AZTEC Study Group.
    Gastroenterology; 2013 Oct 15; 145(4):766-74.e1. PubMed ID: 23770132
    [Abstract] [Full Text] [Related]

  • 13. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
    Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF, Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).
    Gastroenterology; 2013 Oct 15; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 15; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
    Vilien M, Dahlerup JF, Munck LK, Nørregaard P, Grønbaek K, Fallingborg J.
    Aliment Pharmacol Ther; 2004 Jun 01; 19(11):1147-52. PubMed ID: 15153167
    [Abstract] [Full Text] [Related]

  • 16. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
    Abdelli MN, Ben Abdallah H, Houissa F, Bouali MR, Khediri MF.
    Tunis Med; 2007 Jul 01; 85(7):569-72. PubMed ID: 18064988
    [Abstract] [Full Text] [Related]

  • 17. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ, Sfakianakis M, Archavlis E, Petraki K, Christidou A, Karagiannidis A, Triadaphyllou G.
    Am J Gastroenterol; 2004 Jun 01; 99(6):1122-8. PubMed ID: 15180735
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF.
    Am J Gastroenterol; 2000 Jul 01; 95(7):1730-4. PubMed ID: 10925976
    [Abstract] [Full Text] [Related]

  • 19. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 01; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 20. Azathioprine dose escalation in inflammatory bowel disease.
    Rayner CK, Hart AL, Hayward CM, Emmanuel AV, Kamm MA.
    Aliment Pharmacol Ther; 2004 Jul 01; 20(1):65-71. PubMed ID: 15225172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.